Marcia F.T. Rupnow

3.5k total citations
63 papers, 2.6k citations indexed

About

Marcia F.T. Rupnow is a scholar working on Psychiatry and Mental health, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Marcia F.T. Rupnow has authored 63 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Psychiatry and Mental health, 15 papers in Surgery and 13 papers in Pathology and Forensic Medicine. Recurrent topics in Marcia F.T. Rupnow's work include Migraine and Headache Studies (21 papers), Schizophrenia research and treatment (14 papers) and Trigeminal Neuralgia and Treatments (12 papers). Marcia F.T. Rupnow is often cited by papers focused on Migraine and Headache Studies (21 papers), Schizophrenia research and treatment (14 papers) and Trigeminal Neuralgia and Treatments (12 papers). Marcia F.T. Rupnow collaborates with scholars based in United States, Belgium and United Kingdom. Marcia F.T. Rupnow's co-authors include Richard B. Lipton, Dawn C. Buse, Kevin Hawkins, Sara Wang, Robert A. Bailey, Elisabeth Hazard, Julie Munakata, Vivienne J. Zhu, Yi‐Ting Wang and Janice Lopez and has published in prestigious journals such as Neurology, The Journal of Infectious Diseases and Journal of the American Geriatrics Society.

In The Last Decade

Marcia F.T. Rupnow

63 papers receiving 2.5k citations

Peers

Countries citing papers authored by Marcia F.T. Rupnow

Since Specialization

Citations

This map shows the geographic impact of Marcia F.T. Rupnow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcia F.T. Rupnow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcia F.T. Rupnow more than expected).

Fields of papers citing papers by Marcia F.T. Rupnow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcia F.T. Rupnow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcia F.T. Rupnow. The network helps show where Marcia F.T. Rupnow may publish in the future.

Co-authorship network of co-authors of Marcia F.T. Rupnow

This figure shows the co-authorship network connecting the top 25 collaborators of Marcia F.T. Rupnow. A scholar is included among the top collaborators of Marcia F.T. Rupnow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcia F.T. Rupnow. Marcia F.T. Rupnow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Diabetes-related quality measure attainment: canagliflozin versus sitagliptin based on a pooled analysis of 2 clinical trials. 2014 ·PubMed ·Robert A. Bailey, Ujjwala Vijapurkar, Gary Meininger, Marcia F.T. Rupnow, Lawrence Blonde	16
2	Characteristics and short-term outcomes of patients with type 2 diabetes mellitus treated with canagliflozin in a real-world setting 2014 ·Current Medical Research and Opinion ·Erin Buysman, Wing Chow, Henry J. Henk, Marcia F.T. Rupnow	24
3	Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging 2014 ·BMC Research Notes ·Robert A. Bailey, Yi‐Ting Wang, Vivienne J. Zhu, Marcia F.T. Rupnow	182
4	Characterization of Type 2 Diabetes Mellitus Burden by Age and Ethnic Groups Based on a Nationwide Survey 2014 ·Clinical Therapeutics ·Janice Lopez, Robert A. Bailey, Marcia F.T. Rupnow, K. Annunziata	50
5	Electronic Medical Records as a Research Tool: Evaluating Topiramate Use at a Headache Center 2010 ·Headache The Journal of Head and Face Pain ·Michael J. Marmura, Mary Hopkins, Jocelyn Andrel, William B. Young, David M. Biondi, Marcia F.T. Rupnow, R. B. Armstrong	6
6	Topiramate versus amitriptyline in migraine prevention: A 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs 2009 ·Clinical Therapeutics ·David W. Dodick, Fred Freitag, James Banks, Joel R. Saper, Jim Xiang, Marcia F.T. Rupnow, David M. Biondi, Steven J. Greenberg, Joseph Hulihan	103
7	Economic Burden of Transformed Migraine: Results From the American Migraine Prevalence and Prevention (AMPP) Study 2009 ·Headache The Journal of Head and Face Pain ·Julie Munakata, Elisabeth Hazard, Daniel Serrano, David Klingman, Marcia F.T. Rupnow, Jonothan C. Tierce, Michael L. Reed, Richard B. Lipton	229
8	The Burden of Migraine in the United States: Current and Emerging Perspectives on Disease Management and Economic Analysis 2008 ·Value in Health ·Elisabeth Hazard, Julie Munakata, Marcelo E. Bigal, Marcia F.T. Rupnow, Richard B. Lipton	113
9	The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials 2007 ·Health and Quality of Life Outcomes ·Carl Dahlöf, Elizabeth Loder, Merle L. Diamond, Marcia F.T. Rupnow, George Papadopoulos, Lian Mao	35
10	Observed Clinical and Health Services Outcomes in Pediatric Inpatients Treated with Atypical Antipsychotics: 1999–2003 2007 ·Journal of Child and Adolescent Psychopharmacology ·Scott C. Flanders, Robert L. Findling, Eric A. Youngstrom, Gahan Pandina, Marcia F.T. Rupnow, (unknown), Gabrielle A. Carlson	3
11	Cost effectiveness of topiramate in the prevention of migraines in the United States: an update. 2006 ·PubMed ·Jeffrey S. Brown, Marcia F.T. Rupnow, Peter J. Neumann, Mark Friedman, Joseph Menzin	7
12	A Taxonomy and Economic Consequences of Nursing Home Falls 2006 ·Drugs & Aging ·Sonja Sorensen, Gregory de Lissovoy, (unknown), Barbara Resnick, Marcia F.T. Rupnow, Stephanie A. Studenski	33
13	Assessing the Ability of Topiramate to Improve the Daily Activities of Patients With Migraine 2006 ·Mayo Clinic Proceedings ·Jan Lewis Brandes, David Kudrow, John F. Rothrock, Marcia F.T. Rupnow, Diane L. Fairclough, Steven J. Greenberg	31
14	Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: Data from a randomized double-blind trial 2006 ·BMC Psychiatry ·Georges M. Gharabawi, Andrew Greenspan, Marcia F.T. Rupnow, Colette Kosik‐Gonzalez, Cynthia A. Bossie, Young Zhu, Amir H Kalali, A. George Awad	46
15	Cost effectiveness of long-acting risperidone injection versus alternative antipsychotic agents in patients with schizophrenia in the USA 2005 ·PharmacoEconomics ·Natalie C. Edwards, Julie Locklear, Marcia F.T. Rupnow, Ronald J. Diamond	60
16	Psychometric performance of an assessment scale for strain in nursing care: The M-NCAS 2004 ·Health and Quality of Life Outcomes ·Leah Kleinman, Lori Frank, Gabrielle Ciesla, Marcia F.T. Rupnow, Henry Brodaty	16
17	The Effect of Risperidone on Nursing Burden Associated with Caring for Patients with Dementia 2004 ·Journal of the American Geriatrics Society ·Lori Frank, Leah Kleinman, Gabrielle Ciesla, Marcia F.T. Rupnow, Henry Brodaty	24
18	Inpatient length of stay and atypical antipsychotic use among elderly patients with psychiatric disorders and Alzheimer's disease. 2003 ·PubMed ·William S. Edell, Marcia F.T. Rupnow	2
19	Toward Improved Methods for Measurement of Utility: Automated Repair of Errors in Elicitations 2003 ·Medical Decision Making ·Leslie Lenert, (unknown), Marcia F.T. Rupnow	30
20	Helicobacter pyloriVaccine Development and Use: A Cost‐Effectiveness Analysis Using the Institute of Medicine Methodology 1999 ·Helicobacter ·Marcia F.T. Rupnow, Douglas K Owens, Ross D. Shachter, Julie Parsonnet	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact